author-photo

Toshiaki Yoshikawa

Tottori University

62

Papers

1084

Citations

Citation Trend

Filter By

Papers (42) Sort By

Journal Conference Others

Heat Shock Protein 105 as an Immunotherapeutic Target for Patients With Cervical Cancer.

2021 Anticancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Genetic ablation of PRDM1 in antitumor T cells enhances therapeutic efficacy of adoptive immunotherapy.

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Tumor-Infiltrating T Cells Concurrently Overexpress CD200R with Immune Checkpoints PD-1, CTLA-4, and TIM-3 in Non-Small-Cell Lung Cancer

2020 Pathobiology
Show All
- Source
- Cite
- Save
Citations (3)
Efficacy of immunotherapy targeting the neoantigen derived from EGFR T790M/C797S mutation in non-small cell lung cancer.

2020 Cancer Science
Show All
- Source
- Cite
- Save
Citations (3)
Abstract A001: Phase I study of vaccine therapy with a cocktail of peptides for pediatric patients with refractory solid tumors

2019 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)
The higher HLA class I expression in cancer cells at early stage lead to high sensitivity for cytotoxic T lymphocytes

2019 Cancer Science
Show All
- Source
- Cite
- Save
Citations (5)
Prospects for immunotherapy as a novel therapeutic strategy against hepatocellular carcinoma

2019
Show All
- Source
- Cite
- Save
Citations (0)
First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors

2019 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (13)
Abstract LB-019: Anti-CD4 monoclonal antibody immunotherapy exerts an antitumor effect by replacing the T cell receptor repertoire in patients with gastrointestinal cancer

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors

2018 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (27)